Subscribe
Subscribe
Home Tags Mergers and Acquisitions

Tag: Mergers and Acquisitions

An exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London, Friday, May 2, 2014. The board of pharmaceutical company AstraZeneca on Friday rejected drug maker Pfizer's sweetened takeover offer. Pfizer earlier in the day said it is offering 50 pounds ($84) a share in cash and stock, a 7.3 increase on a previous bid. The offer values AstraZeneca at $106 billion. (AP Photo/Matt Dunham)
Business

AstraZeneca rejects sweetened Pfizer takeover bid

DANICA KIRKALINDA A. JOHNSON -
0
Berkshire Hathaway unit buying AltaLink for $2.92B
Business

Berkshire Hathaway unit buying AltaLink for $2.92B

The Associated Press -
0
Rockville, United banks complete merger
Business

Rockville, United banks complete merger

Washington Examiner -
0
AstraZeneca board rejects sweetened takeover offer from Pfizer
Business

AstraZeneca board rejects sweetened takeover offer from Pfizer

Washington Examiner -
0
Comcast, Charter to divvy up nation’s cable subs
Business

Comcast, Charter to divvy up nation’s cable subs

Ryan Nakashima -
0
Pfizer still pursuing AstraZeneca after 2nd rebuff
Business

Pfizer still pursuing AstraZeneca after 2nd rebuff

DANICA KIRKALINDA A. JOHNSON -
0
Charter to buy Time Warner cable subscribers
Business

Charter to buy Time Warner cable subscribers

Washington Examiner -
0
Meda rejects revised offer from Mylan
Business

Meda rejects revised offer from Mylan

The Associated Press -
0
Prestige to buy Insight Pharma for about $750M
Business

Prestige to buy Insight Pharma for about $750M

Washington Examiner -
0
Zimmer buying Biomet in deal valued at $13.35B
Business

Zimmer buying Biomet in deal valued at $13.35B

Washington Examiner -
0
1...343536...39Page 35 of 39
Do Not Sell or Share My Personal Information

NEWS

POLICY

COMMENTARY

RESTORING AMERICA

  • © Copyright 2026. Washington Examiner. All Rights Reserved.